A Vibrio alginolyticus phage GVA-P21 with high fermentation rate and long-lasting antibacterial effect and its application

The screened Vibrio alginolyticus phage GVA-P21 has solved the problems of high morbidity and antibiotic resistance caused by Vibrio alginolyticus in aquaculture, achieving efficient and safe biological control and providing excellent resources for prevention and treatment.

CN114703149BActive Publication Date: 2024-11-22WUHAN GRENON BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210107498.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-01-28
Publication Date
2024-11-22
Estimated Expiration
2042-01-28

AI Technical Summary

Technical Problem

In the existing technology, the incidence of diseases caused by Vibrio alginolyticus in aquaculture is high and the problem of drug resistance caused by antibiotic treatment is serious, and there is a lack of efficient and safe biological control methods.

Method used

The screened Vibrio alginolyticus phage GVA-P21 exhibits high fermentation rate, broad lysis spectrum, and excellent antibacterial effect, and can be used for the prevention and treatment of Vibrio alginolyticus in aquaculture.

Benefits of technology

Vibrio alginolyticus phage GVA-P21 can achieve a titer of 8.24×10¹⁰ PFU/mL and a lysis rate of 95.5% after 6 hours of fermentation at the optimal multiplicity of infection, with an inhibition time of up to 24 hours, providing a safe and non-toxic biocontrol measure.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114703149B_ABST
    Figure CN114703149B_ABST
Patent Text Reader

Abstract

The present invention provides a Vibrio alginolyticus phage GVA-P21 with high fermentation rate and long-lasting antibacterial effect and its application. The Vibrio alginolyticus phage has a deposit number of CCTCC NO: M20211480 and is named GVA-P21. The Vibrio alginolyticus phage GVA-P21 in the present invention has high fermentation efficiency. When MOI=0.01, the titer reaches 8.24×10 10 PFU / mL, and the lysis rate of 355 pathogenic Vibrio alginolyticus strains was as high as 95.5%. The Vibrio alginolyticus phage GVA‑P21 had a long-lasting antibacterial effect on Vibrio alginolyticus, which was more obvious than other phages. Therefore, the Vibrio alginolyticus phage GVA‑P21 has a good preventive and therapeutic effect on diseases caused by Vibrio alginolyticus in aquaculture.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of microbial technology application, and particularly relates to a Vibrio alginolyticus phage GVA-P21 with high fermentation rate and long-lasting antibacterial effect and application thereof. Background Art

[0002] With the rapid development of the marine aquaculture industry and the continuous expansion of intensive aquaculture, the incidence of bacterial diseases in marine aquaculture is increasing. Among the pathogens that cause infection in aquatic animals, pathogenic Vibrio occupies a high proportion, which not only brings high risks to the health of aquatic animals, but also causes serious economic losses to the marine aquaculture industry.

[0003] Common pathogenic Vibrio species in aquatic animals include Vibrio anguillarum, Vibrio harveyi, Vibrio parahaemolyticus and Vibrio alginolyticus. Among them, the number of Vibrio alginolyticus ranks first among marine Vibrio species, and the vibriosis caused by it has the characteristics of high morbidity, high mortality and wide epidemic range. Vibrio alginolyticus can cause human wound infection, food poisoning, otitis media and other diseases, and can also cause outbreaks of vibriosis in marine farmed animals such as fish, shrimp and shellfish. Especially in summer, the outbreak of Vibrio alginolyticus often causes huge economic losses to the aquaculture industry. At present, antibiotics are mainly used to treat vibriosis related to aquaculture. However, with the abuse of antibiotics, more and more pathogenic Vibrio species have developed drug resistance, making the problem of drug resistance of pathogens more serious.

[0004] Bacteriophage refers to a general term for bacterial viruses that infect microorganisms such as bacteria, fungi, actinomycetes or spirochetes. It has a simple structure, strong specificity, and can efficiently lyse host pathogens. Vibrio alginolyticus phage can effectively lyse Vibrio alginolyticus, and has huge advantages and potential in the prevention and treatment of aquaculture.

[0005] The present invention provides a new method for biological control of Vibrio alginolyticus by screening the obtained Vibrio alginolyticus phage GVA-P21 and studying its biological characteristics. Summary of the invention

[0006] One of the purposes of the present invention is to provide a Vibrio alginolyticus phage;

[0007] The second purpose of the present invention is to apply the Vibrio alginolyticus phage to inhibit bacteria.

[0008] In order to achieve the above object, the present invention is implemented through the following technical solutions:

[0009] The applicant isolated a Vibrio alginolyticus phage GVA-P21 in an aquaculture pond in Zhanjiang, Guangdong. The phage was deposited in the China Center for Type Culture Collection on November 23, 2021, with the deposit address being Wuhan University, Wuhan, China; the deposit number is CCTCC NO: M 20211480, and it is named GVA-P21.

[0010] Compared with the prior art, the present invention has the following beneficial effects:

[0011] The Vibrio alginolyticus phage GVA-P21 of the present invention has a high fermentation rate. When the optimal infection multiplicity MOI is 0.01, the titer can reach 8.24×10 10 PFU / mL, providing theoretical data for industrial fermentation.

[0012] The Vibrio alginolyticus phage GVA-P21 of the present invention has a wide lysis spectrum, has a lysis effect on 339 of 355 strains of Vibrio alginolyticus, and a lysis rate of 95.5%, providing an excellent treatment resource and method for the prevention and treatment of Vibrio alginolyticus.

[0013] The Vibrio alginolyticus phage GVA-P21 of the present invention has excellent antibacterial performance, and the antibacterial duration can reach 24 hours. Compared with other phages, it has obvious and intuitive antibacterial effect. At 24 hours, the phage GVA-P21 reduces the OD of Vibrio alginolyticus to 600 The OD of Vibrio alginolyticus in the VAPL1 group was controlled within 0.20. 600 Reaching 1.1, the concentration difference is 5 times.

[0014] The present invention can provide excellent strain resources and biological control measures for the application of phage therapy, which are safe, have no toxic side effects, have strong specificity and can be produced by large-scale fermentation. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] Figure 1 The plaque is the Vibrio alginolyticus phage GVA-P21 of the present invention;

[0016] Figure 2 This is an electron microscope image of the Vibrio alginolyticus phage GVA-P21 of the present invention;

[0017] Figure 3 is the titer of Vibrio alginolyticus phage GVA-P21 at different infection multiplicity of the present invention;

[0018] Figure 4 The pH stability of the Vibrio alginolyticus phage GVA-P21 after different reaction times of the present invention;

[0019] Figure 5 It is the titer of Vibrio alginolyticus phage GVA-P21 after being stored at different temperatures for different time periods;

[0020] Figure 6 The industrial fermentation dynamics of Vibrio alginolyticus phage GVA-P21;

[0021] Figure 7 The dynamic inhibition results of Vibrio alginolyticus phage GVA-P21 and VAPL1. DETAILED DESCRIPTION

[0022] In order to make the technical means, creative features, objectives and effects achieved by the present invention easy to understand, the present invention is further explained below in conjunction with specific implementation methods.

[0023] Embodiment 1:

[0024] Isolation and Purification of Vibrio alginolyticus Phage GVA-P21

[0025] Three water samples were collected from an aquaculture pond in Zhanjiang, Guangdong, each with 50 mL. The samples were centrifuged at 6000 rpm / min for 10 min, the supernatant was taken, and sterilized with a 0.22 μm filter. 5 mL of the treated supernatant was mixed evenly with 0.5 mL of Vibrio alginolyticus (with a concentration of about 5×108 CFU / mL), and after static adsorption for 15 min, the samples were placed in a 28°C incubator and cultured overnight at 150 rpm / min for shaking fermentation. The fermented liquid was centrifuged at 6000 rpm / min for 10 min, the supernatant was taken, and sterilized with a 0.22 μm filter to obtain a seed filtrate. 100 μL of the filtrate was mixed evenly with 300 μL of Vibrio alginolyticus (with a concentration of about 5×108 CFU / mL), and after static adsorption for 15 min, the mixture was mixed evenly with 2% sodium chloride TSB semi-solid (containing 0.65% agar), and poured on a 2% sodium chloride TSA bottom plate. After solidification, the culture dish was placed in a 37°C incubator and cultured overnight. Record the titer of the phage in the culture dish, pick the transparent and bright spots of the plaque on the culture dish, shake and desorb in 1mL SM liquid, and sterilize through a 0.22um microporous filter membrane to obtain the phage filtrate, inoculate it in 5mL 2% sodium chloride TSB liquid culture medium, add 100uL of the corresponding host Vibrio alginolyticus liquid and mix well, statically adsorb for 15min, culture at 37℃ and 150rpm / min overnight, centrifuge at 5000rpm / min for 10min, take the supernatant and filter with a bacterial filter membrane, and observe the morphology of the plaque by the double-layer plate method. After repeating the operation 3-5 times, plaques of uniform shape and size can be obtained.

[0026] Two strains of Vibrio alginolyticus phage were isolated from the water sample, namely GVA-P21 and VAPL1. Phage GVA-P21 forms round and transparent plaques with a diameter of 1 mm with the host bacteria. The phage GVA-P21 was sent to the China Center for Type Culture Collection on November 23, 2021, and was named Vibrio alginolyticus phage (Vibrio alginolyticus phage) GVA-P21. The collection address is Wuhan University, Wuhan, China, and the collection number is CCTCC NO: M 20211480.

[0027] Embodiment 2:

[0028] Experiment on the lysis range of Vibrio alginolyticus phage GVA-P21

[0029] The double-layer drop method was used to determine the lysis spectrum of the bacteriophage. Prepare enough EP tubes containing 3mL of 2% sodium chloride TSB, inoculate 355 strains of Vibrio alginolyticus in the culture medium, and shake at 37℃ and 200rpm / min for 7h to obtain 355 copies of Vibrio alginolyticus liquid; prepare enough TSA bottom plates, mix 0.9ml of Vibrio alginolyticus liquid with 6ml TSB semi-solid culture medium (containing 0.65% agar) at about 50℃, and slowly spread it on the TSA bottom plate; after the plate culture medium solidifies to room temperature, take 7μL of Vibrio alginolyticus phage GVA-P21 solution (titer 1×109PFU / ml) and drop it in the center of the double-layer plate, wait for the solution to dry naturally, and place it in a 37℃ constant temperature biochemical incubator for about 7h, and observe the results. Each group of experiments was repeated 3 times.

[0030] The results are shown in the table. The Vibrio alginolyticus phage GVA-P21 has a high lysis rate. In the lysis experiment of 355 strains of Vibrio alginolyticus, it can lyse 339 of them, with a lysis rate of 95.5%. This shows that the lysis spectrum of Vibrio alginolyticus phage GVA-P21 is relatively wide, and it has great application potential in the prevention and killing of Vibrio alginolyticus in aquaculture.

[0031] Table 1 Experimental results of lysis spectrum of Vibrio alginolyticus phage GVA-P21

[0032]

[0033]

[0034]

[0035]

[0036]

[0037]

[0038] Note: ++: indicates complete lysis, with clear plaques; +: indicates complete lysis, with relatively clear plaques; +: indicates no lysis.

[0039] Embodiment 3:

[0040] Determination of the titer of Vibrio alginolyticus phage GVA-P21 at different infection multiplicity and infection time

[0041] Prepare the host bacteria of Vibrio alginolyticus phage GVA-P21, Vibrio alginolyticus GVA1, prepare an EP tube containing 3mL 2% sodium chloride TSB, pick a single colony of Vibrio alginolyticus VAJS1 and inoculate it in the culture medium, shake and culture it at 37℃ for 8h to obtain the host bacteria liquid. Inoculate the bacterial liquid into 100mL TSB culture medium at an inoculation rate of 1%, wait for Vibrio alginolyticus to grow to the initial logarithmic phase (concentration 1×107CFU / mL), then inoculate Vibrio alginolyticus phage GVA-P21 into the culture medium, according to different multiplicity of infection (MOI; MOI=number of phages / number of bacteria), each group of experiments are 3 parallel. Shake and culture at 150rpm in a 28℃ shaker for 12h. Take out part of the culture solution every 2h, centrifuge it at 8000rpm / min for 10min, collect the supernatant, determine the phage titer, and end the culture after 12h.

[0042] The experimental results are as follows Figure 3 As shown in the figure, at MOI = 0.01, the titer was the highest after 6 h of fermentation, which was 8.24 × 10 10 PFU / mL, providing a theoretical basis for industrial fermentation.

[0043] Example 4

[0044] pH Stability Test of Vibrio alginolyticus Phage GVA-P21

[0045] Take sterile bacterial bottles and add 9 mL of 2% sodium chloride TSB medium with different pH (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13) respectively. Then place the above bacterial bottles in a constant temperature water bath at 25°C. After the temperature is balanced, add 1 mL of pure phage culture solution (initial titer: 3.57×10 8 PFU / mL), and placed in a 25°C environment for 15 min. Samples were taken at 1h, 2h, 4h and 8h, and the phage titer was determined by double-layer plate method after appropriate dilution. Each point was cultured in duplicate tubes to obtain the average value, and the experiment was repeated 3 times.

[0046] The results are as follows Figure 4As shown, the titer of Vibrio alginolyticus phage GVA-P21 did not change significantly when treated in the pH range of 5-10 for 8 hours, but it still had a high titer after being treated in the pH range of 3-12 for 1 hour, and it still had a high titer after being treated in the pH range of 4-11 for 2 hours.

[0047] Embodiment 5:

[0048] Temperature stability test of Vibrio alginolyticus phage GVA-P21

[0049] Take several sterile 50mL centrifuge tubes, add 45mL TSB to each tube and place it in a constant temperature water bath at the corresponding temperature. After the temperature is balanced, add 5mL of pure phage culture solution (starting titer: 3.21×10 8 PFU / mL), and acted at 4℃, 25℃, 37℃, 45℃, 55℃, 65℃, 75℃, 85℃ for 1h, 24h, 48h, 1W, 4W, 8W, 12W, 24W and 48W. After the action time, the sample tube was taken out and immediately placed in an ice bath for cooling. After appropriate dilution, the phage titer was determined by the double-layer plate method. Duplicate culture was performed at each point to obtain the average value, and the experiment was repeated 3 times.

[0050] The results are as follows Figure 5 As shown, the Vibrio alginolyticus phage GVA-P2 in the experimental group can survive more easily at temperatures below 65°C, has good stability at 4-37°C, and can be stored for a long time.

[0051] Embodiment 6:

[0052] Fermentation preparation of Vibrio alginolyticus phage GVA-P21

[0053] A single colony was picked from the host bacteria Vibrio alginolyticus GVA1 plate, inoculated in 3mL of 2% sodium chloride TSB medium, and cultured at 37°C at 150rpm / min for 8h to obtain the host bacterial solution. The bacterial suspension was inoculated in 100mL of 2% sodium chloride TSB medium at 1% inoculation amount, and cultured at 37°C at 150rpm / min to the early logarithmic phase. The fermentation system was 6L, the fermentation medium was ordinary TSB medium, and the initial pH value was 7.0; the flame method was used to inoculate Vibrio alginolyticus at a 1% inoculation amount, and the phage was added to the fermentation system at the optimal infection multiplicity MOI = 0.01. After the phage was connected, it was required to be statically adsorbed for 15min. Sterile air was introduced during the fermentation process, and 3‰ defoaming agent was added. The fermentation preparation time was 12h. From the beginning of fermentation, 20 ml of fermentation liquid was taken from the sampling port every 2 hours into a sterile container, centrifuged at 5000 rpm for 10 min, and the supernatant was sterilized by passing through a 0.22 μm microporous filter membrane to obtain a filtrate containing bacteriophages and determine its titer, as described in Example 2. After the fermentation was completed, the entire mixture of bacteriophages and host bacteria was taken out from the sampling port and placed in a sterile container, centrifuged at 6000 rpm for 15 min, and the supernatant was filtered into a sterile filter device through a vacuum pump to obtain a bacteriophage fermentation liquid and stored at 4°C.

[0054] Depend on Figure 6 It can be seen that the titer of Vibrio alginolyticus phage GVA-P21 reached the highest level at 6 h of fermentation, which was 7.69×10 10 PFU / ml, in the period of 6h to 12h, the titer is stable at 10 10 PFU / ml; therefore, it is feasible to use fermentation method for large-scale industrial preparation of phages.

[0055] Example 7

[0056] Dynamic inhibition experiment of bacteriophage GVA-P21 and VAPL1 against Vibrio alginolyticus, the experimental settings are as follows:

[0057] (1) Prepare bacteriophage GVA-P21 (5×10 7 PFU / ml) and VAPL1 (5×10 7 PFU / ml) seed solution;

[0058] (2) The host Vibrio alginolyticus was inoculated into TSB medium containing 2% sodium chloride and the OD of the host bacteria was 600 When the value reaches about 0.6, the host bacterial solution is transferred to 2% sodium chloride TSB medium at a ratio of 1:100, and 1% of the volume of the culture medium is added with bacteriophage, and it is left to stand for 15 minutes; in addition, a host Vibrio alginolyticus control group is set up;

[0059] (3) After the rest period, all the cells were placed in a constant temperature incubator and cultured at 37°C and 150 rpm / min. The OD of the bacterial solution was detected at 0 h, 1 h, 2 h, 3 h, 4 h, 5 h, 6 h, 8 h, 10 h, 12 h, 24 h, 36 h, and 48 h. 600 values, and record the data and analyze them.

[0060] The experimental results are as follows Figure 7 As shown in the figure, phage GVA-P21 has excellent antibacterial performance, and the antibacterial duration can reach 24 hours. Compared with phage VAPL1, it has obvious and intuitive antibacterial effect. At 24 hours, phage GVA-P21 reduces the OD of Vibrio alginolyticus to 600 The OD of Vibrio alginolyticus in the VAPL1 group was suppressed to less than 0.2. 600 Reaching 1.1, the concentration difference was 5 times; compared with the blank group, the phage GVA-P21 group was about 4.5 times lower than the GVA1 group, and the antibacterial effect was obvious.

[0061] The above shows and describes the basic principles and main features of the present invention and the advantages of the present invention. It is obvious to those skilled in the art that the present invention is not limited to the details of the above exemplary embodiments, and the present invention can be implemented in other specific forms without departing from the spirit or basic features of the present invention. Therefore, no matter from which point of view, the embodiments should be regarded as exemplary and non-restrictive. The scope of the present invention is defined by the attached claims rather than the above description, and it is intended that all changes falling within the meaning and scope of the equivalent elements of the claims are included in the present invention. Any figure mark in the claims should not be regarded as limiting the claims involved.

[0062] In addition, it should be understood that although the present specification is described according to implementation modes, not every implementation mode contains only one independent technical solution. This description of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation modes that can be understood by those skilled in the art.

Claims

1. An isolated Vibrio alginolyticus phage, characterized in that: Its preservation number is CCTCC NO: M 20211480, and it is named GVA-P21. Within 24 hours, the Vibrio alginolyticus phage GVA-P21 controls the OD600 of Vibrio alginolyticus within 0.

20. Its potency has no obvious change after treatment in the pH range of 5-10 for 8 hours. It has good stability at 4-37°C, and the potency order of magnitude after storage for 12 weeks is the same as the original potency order of magnitude.

2. The use of the Vibrio alginolyticus phage according to claim 1, characterized in that: Used in the preparation of antibacterial products.